Solid Biosciences Inc.
BalancedSLDB·US·🇺🇸 US
46%buys·54%sells
511 transactions$752.4MTotal buys·60 buys
$5.4MTotal sells·70 sells
4949 insiders
Last: Apr 2, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 2, 26 | SMITH IAN F | Exercise | - | |
| Apr 2, 26 | SMITH IAN F | Exercise | - | |
| Dec 3, 25 | Herzich Paul | Sell | $14K | |
| Dec 3, 25 | Hanrahan Jessie | Sell | $23K | |
| Dec 3, 25 | Cumbo Alexander | Sell | $55K | |
| Dec 3, 25 | Howton David T | Sell | $25K | |
| Dec 2, 25 | Herzich Paul | Exercise | - | |
| Dec 2, 25 | Hanrahan Jessie | Exercise | - | |
| Dec 2, 25 | Cumbo Alexander | Exercise | - | |
| Dec 2, 25 | Howton David T | Exercise | - |
Solid Biosciences Inc. is seeing coordinated insider selling. 4 insiders sold shares in the last 30 days, with total sell volume of $117K. Insider activity shows a balanced mix of buying and selling.
Solid Biosciences Inc. (SLDB) has recorded 511 insider operations, including 60 open-market purchases ($752.4M), 70 sales ($5.4M) and 381 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Insider activity at Solid Biosciences Inc. is sustained, with operations recorded in 8 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are Ganot Ilan (CEO), Cumbo Alexander (CEO) & Ziolkowski Jennifer Lynn (CFO), with respectively 81, 76, 29 transactions.
Across all 512 recorded transactions, the breakdown by type is: grant (237, 46%), exercise (133, 26%), sells (70, 14%), buys (60, 12%), other (8, 2%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Solid Biosciences Inc. has recorded 511 insider operations in total, including 60 open-market purchases ($752.4M), 70 sales ($5.4M) and 381 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 2, 2026.
Insiders at Solid Biosciences Inc. show balanced activity with 46% purchases and 54% sales. Total buy volume is $752.4M versus $5.4M in sales.
InsiderLens tracks 49 insiders at Solid Biosciences Inc. (SLDB). Ganot Ilan (CEO, 81 tx), Cumbo Alexander (CEO, 76 tx), Ziolkowski Jennifer Lynn (CFO, 29 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for SLDB is neutral, based on a 46% buy ratio across 130 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Solid Biosciences Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.